Increased gestational palmitic acid predisposes offspring to congenital heart disease

Yang Lv1, Ri-Feng Gao1, Chen-Xi Yang1

  • 1Department of Cardiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

Cell Reports. Medicine
|March 22, 2023
PubMed

Insights

Gestational exposure to palmitic acid (PA) increases congenital heart disease (CHD) risk in offspring. This occurs by disrupting the MARS/K-Hcy/GATA4 signaling pathway, offering targets for prevention and treatment.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Metabolomics

Background:

  • Congenital heart disease (CHD) poses a significant global health challenge.
  • Understanding the etiology of CHD is crucial for effective prevention and personalized therapies.

Purpose of the Study:

  • To investigate the role of gestational serum palmitic acid (PA) in the development of congenital heart disease (CHD).
  • To elucidate the molecular mechanisms by which PA influences CHD pathogenesis.

Main Methods:

  • Analysis of gestational serum palmitic acid levels.
  • Investigation of the MARS/K-Hcy/GATA4 signaling pathway in affected offspring.
  • Correlation studies between PA levels and CHD incidence.

Main Results:

  • Elevated gestational serum palmitic acid (PA) levels were found to be associated with an increased risk of congenital heart disease (CHD) in offspring.
  • PA was demonstrated to perturb the MARS/K-Hcy/GATA4 signaling pathway, a critical pathway in heart development.

Conclusions:

  • Gestational palmitic acid exposure is a potential risk factor for congenital heart disease.
  • The MARS/K-Hcy/GATA4 pathway is a key mediator of PA-induced cardiotoxicity, presenting a potential therapeutic target for CHD.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
210
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.0K
Pedigree Analysis01:35

Pedigree Analysis

Overview
84.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39